Correspondence 0001193125-23-251675 from Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: Oct. 5, 2023 · CIK: 0001811115 · Accession: 0001193125-23-251675
AI Filing Summary & Sentiment
File numbers found in text: 333-265280, 333-271579, 333-274733
Letter
Finsgate
5-7 Cranwood Street
London EC1V 9EE
United Kingdom
October 5, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Conlon Danberg
Re:
Renalytix plc
Registration Statement on Form S-3
Filed September 28, 2023
File No. 333-274733
Post-Effective Amendment No. 1 to Form F-3 on Form S-3
Filed September 28, 2023
File No. 333-271579
and
Post-Effective Amendment No. 2 to Form F-3 on Form S-3
Filed September 28, 2023
File No. 333-265280
Acceleration Request
Requested Date:
October 6, 2023
Requested Time:
5:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-274733) (the “Registration Statement”) to become effective at 5:00 p.m. Eastern Time on October 6, 2023, or as soon thereafter as is practicable.
The undersigned registrant also requests that the two post-effective amendments referenced above be declared effective at the same time as the Registration Statement.
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043.
[Signature page follows]
Very truly yours,
RENALYTIX PLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP Finsgate 5-7 Cranwood Street London EC1V 9EE United Kingdom October 5, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Conlon Danberg Re: Renalytix plc Registration Statement on Form S-3 Filed September 28, 2023 File No. 333-274733 Post-Effective Amendment No. 1 to Form F-3 on Form S-3 Filed September 28, 2023 File No. 333-271579 and Post-Effective Amendment No. 2 to Form F-3 on Form S-3 Filed September 28, 2023 File No. 333-265280 Acceleration Request Requested Date: October 6, 2023 Requested Time: 5:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-274733) (the “Registration Statement”) to become effective at 5:00 p.m. Eastern Time on October 6, 2023, or as soon thereafter as is practicable. The undersigned registrant also requests that the two post-effective amendments referenced above be declared effective at the same time as the Registration Statement. Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043. [Signature page follows] Very truly yours, RENALYTIX PLC By: /s/ James McCullough James McCullough Chief Executive Officer cc: O. James Sterling, Renalytix plc Marc Recht, Cooley LLP Madison Jones, Cooley LLP Katie Kazem, Cooley LLP